Name

This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 10).

This instrument may also be cited as PB 131 of 2024.

(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

Commencement information
Column 1	Column 2	Column 3
Provisions	Commencement	Date/Details
1. The whole of this instrument	1 December 2024

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

3 Authority

This instrument is made under section 85B of the National Health Act 1953.

4 Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1 – Amendments

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

Schedule 1 – entry for Amlodipine with valsartan

Omit

Amlodipine with valsartan	Tablet 5 mg (as besilate)‑80 mg	Oral	Exforge 5/80	28	7.42	11.14
	Tablet 5 mg (as besilate)‑160 mg	Oral	Exforge 5/160	28	9.31	13.03
	Tablet 5 mg (as besilate)‑320 mg	Oral	Exforge 5/320	28	11.72	15.44
	Tablet 10 mg (as besilate)‑160 mg	Oral	Exforge 10/160	28	9.80	13.52
	Tablet 10 mg (as besilate)‑320 mg	Oral	Exforge 10/320	28	11.91	15.63

Insert

Amlodipine with valsartan	Tablet 5 mg (as besilate)‑80 mg	Oral	Exforge 5/80	28	7.42	13.00
	Tablet 5 mg (as besilate)‑160 mg	Oral	Exforge 5/160	28	9.31	14.89
	Tablet 5 mg (as besilate)‑320 mg	Oral	Exforge 5/320	28	11.72	17.30
	Tablet 10 mg (as besilate)‑160 mg	Oral	Exforge 10/160	28	9.80	15.38
	Tablet 10 mg (as besilate)‑320 mg	Oral	Exforge 10/320	28	11.91	17.49

Schedule 1 – entry for Amlodipine with valsartan and hydrochlorothiazide

Omit

Amlodipine with valsartan and hydrochlorothiazide	Tablet 5 mg (as besilate)‑160 mg‑12.5 mg	Oral	Exforge HCT 5/160/12.5	28	10.72	20.02
	Tablet 5 mg (as besilate)‑160 mg‑25 mg	Oral	Exforge HCT 5/160/25	28	12.13	15.85
	Tablet 10 mg (as besilate)‑160 mg‑12.5 mg	Oral	Exforge HCT 10/160/12.5	28	11.21	14.93
	Tablet 10 mg (as besilate)‑160 mg‑25 mg	Oral	Exforge HCT 10/160/25	28	12.62	21.92
	Tablet 10 mg (as besilate)‑320 mg‑25 mg	Oral	Exforge HCT 10/320/25	28	14.73	18.45

Insert

Amlodipine with valsartan and hydrochlorothiazide	Tablet 5 mg (as besilate)‑160 mg‑12.5 mg	Oral	Exforge HCT 5/160/12.5	28	10.72	21.88
	Tablet 5 mg (as besilate)‑160 mg‑25 mg	Oral	Exforge HCT 5/160/25	28	12.13	17.71
	Tablet 10 mg (as besilate)‑160 mg‑12.5 mg	Oral	Exforge HCT 10/160/12.5	28	11.21	16.79
	Tablet 10 mg (as besilate)‑160 mg‑25 mg	Oral	Exforge HCT 10/160/25	28	12.62	23.78
	Tablet 10 mg (as besilate)‑320 mg‑25 mg	Oral	Exforge HCT 10/320/25	28	14.73	20.31

Schedule 1 – entry for Brinzolamide

Omit

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Application to the eye

Azopt

9.06

12.10

Insert

Brinzolamide

Eye drops 10 mg per mL, 5 mL

Application to the eye

Azopt

9.06

13.52

Schedule 1 – entry for Carbamazepine

Omit

Carbamazepine	Tablet 100 mg	Oral	Tegretol 100	100	4.85	6.08
	Tablet 200 mg	Oral	Tegretol 200	100	8.10	9.32

Insert

Carbamazepine	Tablet 100 mg	Oral	Tegretol 100	100	4.85	6.98
	Tablet 200 mg	Oral	Tegretol 200	100	8.10	10.24

Schedule 1 – entry for Ciprofloxacin

Omit

Ciprofloxacin

Eye drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Ciloxan

8.92

10.95

Insert

Ciprofloxacin

Eye drops 3 mg (as hydrochloride) per mL, 5 mL

Application to the eye

Ciloxan

14.05

18.47

Schedule 1 – after entry for Cyproterone

Insert

Dabigatran etexilate	Capsule 110 mg (as mesilate)	Oral	Pradaxa	60	6.19	46.44
	Capsule 150 mg (as mesilate)	Oral	Pradaxa	60	36.88	46.18

Schedule 1 – entry for Diclofenac

Omit

Diclofenac	Tablet (enteric coated) containing diclofenac sodium 25 mg	Oral	Voltaren 25	50	2.50	4.10
	Tablet (enteric coated) containing diclofenac sodium 50 mg	Oral	Voltaren 50	50	2.50	5.71

Insert

Diclofenac	Tablet (enteric coated) containing diclofenac sodium 25 mg	Oral	Voltaren 25	50	2.50	4.83
	Tablet (enteric coated) containing diclofenac sodium 50 mg	Oral	Voltaren 50	50	2.50	7.31

Schedule 1 – omit entry for Ezetimibe with atorvastatin

Omit

Ezetimibe with atorvastatin	Tablet 10 mg‑10 mg	Oral	Atozet	30	6.97	8.97
	Tablet 10 mg‑20 mg	Oral	Atozet	30	7.49	9.50
	Tablet 10 mg‑40 mg	Oral	Atozet	30	8.33	10.40
	Tablet 10 mg‑80 mg	Oral	Atozet	30	9.25	11.31

Insert

Ezetimibe with atorvastatin

Tablet 10 mg‑20 mg

Oral

Atozet

7.49

9.50

Schedule 1 – omit entry for Ketoprofen
Schedule 1 – entry for Letrozole

Omit

Letrozole

Tablet 2.5 mg

Oral

Femara 2.5 mg

9.72

12.17

Insert

Letrozole

Tablet 2.5 mg

Oral

Femara 2.5 mg

9.72

14.37

Schedule 1 – entry for Medroxyprogesterone

Omit

Medroxyprogesterone	Injection containing medroxyprogesterone acetate 150 mg in 1 mL	Injection	Depo‑Provera	1	13.14	19.65
	Tablet containing medroxyprogesterone acetate 5 mg	Oral	Provera	56	5.10	9.36
	Tablet containing medroxyprogesterone acetate 10 mg	Oral	Provera	30	6.39	12.62

Insert

Medroxyprogesterone	Tablet containing medroxyprogesterone acetate 5 mg	Oral	Provera	56	5.10	9.36
	Tablet containing medroxyprogesterone acetate 10 mg	Oral	Provera	30	6.39	12.62

Schedule 1 – after entry for Metronidazole

Insert

Minocycline

Tablet 50 mg (as hydrochloride)

Oral

Minomycin-50

8.51

11.51

Schedule 1 – after entry for Perindopril with indapamide

Insert

Pramipexole	Tablet containing pramipexole dihydrochloride monohydrate 125 micrograms	Oral	Sifrol	30	3.04	6.54
	Tablet containing pramipexole dihydrochloride monohydrate 250 micrograms	Oral	Sifrol	100	13.75	17.25

Schedule 1 – entry for Pregabalin

Omit

Pregabalin	Capsule 75 mg	Oral	Lyrica	56	4.68	9.20
	Capsule 150 mg	Oral	Lyrica	56	7.19	12.72

Insert

Pregabalin	Capsule 25 mg	Oral	Lyrica	56	3.73	5.71
	Capsule 75 mg	Oral	Lyrica	56	4.68	9.20
	Capsule 150 mg	Oral	Lyrica	56	7.19	12.72
	Capsule 300 mg	Oral	Lyrica	56	10.72	12.58

Schedule 1 – entry for Telmisartan

Omit

Telmisartan	Tablet 40 mg	Oral	Micardis	28	2.50	7.71
	Tablet 80 mg	Oral	Micardis	28	4.00	8.17

Insert

Telmisartan	Tablet 40 mg	Oral	Micardis	28	2.50	11.82
	Tablet 80 mg	Oral	Micardis	28	4.00	13.30

Schedule 1 – entry for Telmisartan with hydrochlorothiazide

Omit

Telmisartan with hydrochlorothiazide	Tablet 40 mg‑12.5 mg	Oral	Micardis Plus 40/12.5 mg	28	2.62	7.78
	Tablet 80 mg‑12.5 mg	Oral	Micardis Plus 80/12.5 mg	28	4.00	7.73
	Tablet 80 mg‑25 mg	Oral	Micardis Plus 80/25 mg	28	4.31	8.00

Insert

Telmisartan with hydrochlorothiazide	Tablet 40 mg‑12.5 mg	Oral	Micardis Plus 40/12.5 mg	28	2.62	11.93
	Tablet 80 mg‑12.5 mg	Oral	Micardis Plus 80/12.5 mg	28	4.00	13.30
	Tablet 80 mg‑25 mg	Oral	Micardis Plus 80/25 mg	28	4.31	13.61

Schedule 1 – after entry for Temazepam

Insert

Terbinafine

Tablet 250 mg (as hydrochloride)

Oral

Lamisil (Novartis Pharmaceuticals Australia Pty Ltd)

11.88

18.62

Schedule 1 – entry for Valproic acid

Omit

Valproic Acid	Tablet (enteric coated) containing sodium valproate 200 mg	Oral	Epilim EC	100	4.00	4.68
	Tablet (enteric coated) containing sodium valproate 500 mg	Oral	Epilim EC	100	7.47	8.11

Insert

Valproic Acid	Tablet (enteric coated) containing sodium valproate 200 mg	Oral	Epilim EC	100	5.12	5.99
	Tablet (enteric coated) containing sodium valproate 500 mg	Oral	Epilim EC	100	9.95	10.80